What are the implications of risk factor reduction and improved treatment for venous insufficiency?

Updated: Sep 25, 2020
  • Author: Robert Weiss, MD; Chief Editor: William D James, MD  more...
  • Print

The importance of addressing CVI resides in the fact that over 2.5 million individuals have this disorder, from which around 20% percent present with venous ulcers as a complication. [21] Therefore, a reduction in the quality of life, exposure to financial constraints, and disability are frequently seen in this type of patient. The estimated annual expenditures dedicated to the management of venous ulcer disease exceeds $1 billion; hence, it is important to reduce the risk factors and increase the therapeutic options that could prevent disease and disability from complications of CVI.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!